Interestingly, we did not observe any change in protein expression of other PRC1 members other than the PRC1.1 member KDM2B in erdafitinib-treated MCL cells, raising the possibility of KDM2B regulation by FGFR1 in MCL. The gene discussed is FGFR1; the disease is mantle cell lymphoma.